NZ Rare 8 Hamed.png (40.42 kB)

Economic Evaluation of Tobramycin Inhalation Powder for the Treatment of Chronic Pulmonary Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis

Download (40.42 kB)
figure
posted on 28.02.2018 by Srilekha Panguluri, Praveen Gunda, Laurie Debonnett, Kamal Hamed

The full text of this article can be found here:

https://link.springer.com/article/10.1007/s40261-017-0537-9

Funding

Novartis Pharma AG.

History

Licence

Exports

Logo branding

Licence

Exports